2018 | HFSA

FDA Approves Impella Ventricular Support Systems

Practice News Industry

FDA has recently approved the Impella Ventricular Support Systems to be marketed.

FDA has recently approved the Impella Ventricular Support Systems to be marketed. The Impella Ventricular Support Systems are left-side heart pump systems intended to help pump blood in patients who need short-term support (up to 6 days). The system includes a mini heart pump (Impella 2.5, Impella CP, or Impella 5.0/LD) mounted at the end of a thin, flexible tube (catheter), a console that drives the pump, and an infusion system that flushes the pump. For more information and to read the full article, visit the FDA website.

This post is for information purposes only and may contain links to a third party website. Content created by third parties is the sole responsibility of the third parties and its accuracy and completeness are not endorsed or guaranteed by the Heart Failure Society of America, Inc.